Microemulsion formulation for enhanced absorption of poorly soluble drugs: II. In vivo study
Introduction
Recent progress in combinatorial chemistry has made possible automatic production of a great member of new compounds. Today, a good chemist may synthesize thousands or tens of thousands compounds per year, while only 50 to 100 compounds could have been produced by the same chemist 10 years ago [1]. However, these automatically produced compounds often show poorly-soluble behavior against water and their bioavailability is usually low. Techniques to enhance their absorption after oral administration is very important.
Many techniques have been developed to enhance the absorption of poorly-soluble drugs [2], [3], [4], [5]. Most of them increase surface area of drugs to improve solubilization behavior. One promising technology is the self-emulsifying drug delivery system (SEDDS) [6], [7]. The SEDDS is a mixture of an oil and a surfactant which contains drugs, and it forms oil-in-water emulsion spontaneously in aqueous media under mild agitation. When it is administered to men, emulsion droplets should be smaller than those in vitro, because bile salts would be incorporated into the surfactant layers of the emulsion droplets. The great increase in the interfacial area promotes release of the drug molecules from the droplets and their absorption. The SEDDS is reported to improve the reproducibility of the plasma profile [6] and bioavailability [7].
Recently, various efforts have been made to utilize microemulsion (ME) [8], [9] as a formulation technique [10], [11], [12], [13], [14], [15], and it has been applied to a formulation of a poorly-soluble immunosuppressant for oral administration [12], [13], [14]. The enhancing mechanism of ME formulation is very similar to that of an SEDDS. However, it is less affected by bile salts, because it can form very small droplets ranging from ca. 1 to 100 nm without their participation. This suggests that the absorption behavior of drugs would be less affected by the amount of the bile salts compared to an SEDDS. It has been reported to make the plasma concentration profiles and bioavailability of drugs more reproducible than an SEDDS [12], [13], [14].
The administration of the oral ME formulation is achieved by a soft capsule which contains an oil solution of drug and surfactants. In the previous paper [10], we proposed various types of ME formulation prescriptions. The most suitable surfactants among those tested were HCO-40, HCO-60, Tween 80, BL-9EX, and Pluronic P84. Notably, Tween 80 and BL-9EX could form ME without the aid of cosurfactants. Propyleneglycol monoalkyl ester and glycerol monoalkyl ester were the most suitable oils for solubilization into the surfactant solutions, and enhanced solubility was observed by mixing different types of oils. This study investigated the effectiveness of these ME formulations in vivo.
Section snippets
Materials
The oils and surfactants used in this study were the same as those of the previous paper [10]. Nitrendipine was obtained from Wako Pure Chemical (Osaka, Japan). All the reagents were of the highest purity available and used as supplied.
Preparation of formulations
The prescription of each formulation is listed in Table 1. The compositions of the ME formulations were based on the solubilization study of oil into 10 wt% surfactant solutions as shown in Fig. 1 (see Results). The detailed procedure of this experiment was
Prescription of ME formulations
We found several types of ME formulations in the previous study [10]. Some were formed with only nonionic surfactants, while others needed highly surface-active charged surfactants. Fig. 1 shows examples of the screening study. When a small amount of MCG/DCPG mixture was added periodically to the 10 wt% C12E9 solution at 37 °C, it solubilized 10 wt% oil independent of the presence of SDS as a cosurfactant. Tw80 solution solubilized 20 wt% of oil in the absence of SDS, but the solubilization
Discussion
ME formulations are considered to be a promising formulation technique, because the enhanced absorption of poorly-soluble drug becomes more and more important problem to overcome recently. The reality of this type of formulation was proved by the launch of the immunosuppressant formulation. However, much remains unknown about ME formulations. For example, we hardly know what kind of ME formulation is effective. Our in vivo study showed that three ME formulations exhibited different absorption
Conclusions
Oral administration study of three types of ME formulations was performed using rats. The effect of the fed state was reduced for all the ME formulations compared to the suspension and the solution. This is likely to be due to the ME droplets mimicking bile salt micelles. Enhanced and prompt absorption were also observed but depended on the type of surfactant used. It was suggested that too stable ME, that is, one which formed very quickly and has sterically protected interfacial structure, is
References (21)
- et al.
Dissolution behaviour and characterization of diazepam–pullulan coground mixtures
Int. J. Pharm.
(1993) - et al.
Improving drug solubility for oral delivery using solid dispersions
Eur. J. Pharm. Biopharm.
(2000) - et al.
Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycosides for improving in vitro dissolution and oral absorption of lipophilic drugs
Int. J. Pharm.
(1994) - et al.
Structure, dynamics and transport properties of microemulsions
Adv. Colloid Interface Sci.
(1998) - et al.
Lecithin organogel as matrix for transdermal transport of drugs
J. Pharm. Sci.
(1992) - et al.
Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation
J. Pharm. Sci.
(1994) Combinatorial chemistry
Chem. Eng. News
(1998)- et al.
Bioavailability of microsize and ultramicrosize griseofulvin products in man
J. Pharmacokin. Biopharm.
(1980) Absorption enhancers
Crit. Rev. Ther. Drug Carrier Syst.
(1990)- et al.
Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound
Pharm. Res.
(1992)